Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan

Despite the first approval of biosimilars’ in 2010, biosimilar products usage has remained low in Taiwan. This cross-sectional survey study assessed healthcare professionals’ (HCPs)—hospital pharmacists, oncologists, and rheumatologists—knowledge, and attitudes toward biosimilars. More precisely, th...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Samantha Yun-Kai Poon, Jason C. Hsu, Yu Ko, Shao-Chin Chiang
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	biosimilar healthcare professional survey questionnaire Medicine R
Acceso en línea:	https://doaj.org/article/24f10e340e724dc19cd37177c1b0e186
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:24f10e340e724dc19cd37177c1b0e186
record_format	dspace
spelling	oai:doaj.org-article:24f10e340e724dc19cd37177c1b0e1862021-11-25T17:46:49ZAssessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan10.3390/healthcare91116002227-9032https://doaj.org/article/24f10e340e724dc19cd37177c1b0e1862021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9032/9/11/1600https://doaj.org/toc/2227-9032Despite the first approval of biosimilars’ in 2010, biosimilar products usage has remained low in Taiwan. This cross-sectional survey study assessed healthcare professionals’ (HCPs)—hospital pharmacists, oncologists, and rheumatologists—knowledge, and attitudes toward biosimilars. More precisely, their knowledge and attitude towards biosimilars’ current usage and regulations in Taiwan were analyzed. The mean ± standard deviation knowledge score was 2.56 ± 0.86 out of 4 (<i>n</i> = 395), and a difference in knowledge score was determined according to the hospital types (<i>p</i> = 0.004). Rheumatologists possessed significantly higher confidence in their knowledge of biosimilars than other HCPs (<i>p</i> = 0.001). Pharmacists showed the highest acceptance—and rheumatologists the least—for switching patients from reference drugs to biosimilars (<i>p</i> = 0.02). Hospital type was associated with the respondent’s confidence in their knowledge (<i>p</i> = 0.04) and the preference for distinguishable naming of biosimilars (<i>p</i> = 0.007). Their knowledge scores were associated with their confidence in the efficacy and safety of biosimilars (<i>p</i> = 0.02). The study found that the current level of biosimilar knowledge of HCPs in Taiwan is low. The higher the knowledge score, the greater the confidence in biosimilars and the familiarity with relevant regulations.Samantha Yun-Kai PoonJason C. HsuYu KoShao-Chin ChiangMDPI AGarticlebiosimilarhealthcare professionalsurvey questionnaireMedicineRENHealthcare, Vol 9, Iss 1600, p 1600 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	biosimilar healthcare professional survey questionnaire Medicine R
spellingShingle	biosimilar healthcare professional survey questionnaire Medicine R Samantha Yun-Kai Poon Jason C. Hsu Yu Ko Shao-Chin Chiang Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
description	Despite the first approval of biosimilars’ in 2010, biosimilar products usage has remained low in Taiwan. This cross-sectional survey study assessed healthcare professionals’ (HCPs)—hospital pharmacists, oncologists, and rheumatologists—knowledge, and attitudes toward biosimilars. More precisely, their knowledge and attitude towards biosimilars’ current usage and regulations in Taiwan were analyzed. The mean ± standard deviation knowledge score was 2.56 ± 0.86 out of 4 (<i>n</i> = 395), and a difference in knowledge score was determined according to the hospital types (<i>p</i> = 0.004). Rheumatologists possessed significantly higher confidence in their knowledge of biosimilars than other HCPs (<i>p</i> = 0.001). Pharmacists showed the highest acceptance—and rheumatologists the least—for switching patients from reference drugs to biosimilars (<i>p</i> = 0.02). Hospital type was associated with the respondent’s confidence in their knowledge (<i>p</i> = 0.04) and the preference for distinguishable naming of biosimilars (<i>p</i> = 0.007). Their knowledge scores were associated with their confidence in the efficacy and safety of biosimilars (<i>p</i> = 0.02). The study found that the current level of biosimilar knowledge of HCPs in Taiwan is low. The higher the knowledge score, the greater the confidence in biosimilars and the familiarity with relevant regulations.
format	article
author	Samantha Yun-Kai Poon Jason C. Hsu Yu Ko Shao-Chin Chiang
author_facet	Samantha Yun-Kai Poon Jason C. Hsu Yu Ko Shao-Chin Chiang
author_sort	Samantha Yun-Kai Poon
title	Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
title_short	Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
title_full	Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
title_fullStr	Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
title_full_unstemmed	Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
title_sort	assessing knowledge and attitude of healthcare professionals on biosimilars: a national survey for pharmacists and physicians in taiwan
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/24f10e340e724dc19cd37177c1b0e186
work_keys_str_mv	AT samanthayunkaipoon assessingknowledgeandattitudeofhealthcareprofessionalsonbiosimilarsanationalsurveyforpharmacistsandphysiciansintaiwan AT jasonchsu assessingknowledgeandattitudeofhealthcareprofessionalsonbiosimilarsanationalsurveyforpharmacistsandphysiciansintaiwan AT yuko assessingknowledgeandattitudeofhealthcareprofessionalsonbiosimilarsanationalsurveyforpharmacistsandphysiciansintaiwan AT shaochinchiang assessingknowledgeandattitudeofhealthcareprofessionalsonbiosimilarsanationalsurveyforpharmacistsandphysiciansintaiwan
_version_	1718412032144834560

Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan

Ejemplares similares